Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:102-107

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vatner, D. E.
Right arrow Articles by Vatner, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vatner, D. E.
Right arrow Articles by Vatner, S. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBACHOL CHLORIDE
Medline Plus Health Information
*Heart Failure

(Circulation. 1996;94:102-107.)
© 1996 American Heart Association, Inc.


Articles

Physiological and Biochemical Evidence for Coordinate Increases in Muscarinic Receptors and Gi During Pacing-Induced Heart Failure

Dorothy E. Vatner, MD; Naoki Sato, MD; Jonas B. Galper, MD, PhD; Stephen F. Vatner, MD

From the Departments of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, and Massachusetts General Hospital, Boston, and the New England Regional Primate Research Center, Southborough, Mass.

Correspondence to Dorothy E. Vatner, MD, New England Regional Primate Research Center, 1 Pine Hill Dr, PO Box 9102, Southborough, MA 01772-9102.

Background It is not clear whether the increase in the myocardial guanylyl nucleotide inhibitory protein (Gi), frequently observed in heart failure, is associated with any functional effects.

Methods and Results Eight sham-operated dogs and 10 dogs were studied with pacing-induced heart failure (240 bpm for 4 to 7 weeks), characterized by reduced (P<.05) left ventricular dP/dt (from 2926±99 to 1303±126 mm Hg/s). The muscarinic agonist acetylcholine (10 µg/kg IV) in the presence of ganglionic blockade reduced left ventricular dP/dt more (P<.05) in heart failure (-23±2%) than before heart failure (-8±2%), despite lesser reductions in arterial pressure. Gi{alpha}2 was increased by 55% in heart failure. Dose-response curves for carbachol (10-8 to 10-3 mol/L) inhibition of isoproterenol-stimulated adenylyl cyclase demonstrated significantly greater (P<.05) inhibition in heart failure compared with sham-operated dogs. These changes were associated with a coordinate increase in muscarinic receptor density, determined by antagonist binding with 3H-quinuclidinyl benzilate, in heart failure (153±6.2 fmol/mg protein) compared with sham-operated dogs (124±7.4 fmol/mg protein). Agonist binding with carbachol also revealed an increase in total muscarinic receptors in heart failure without a change in fraction of high- and low-affinity receptors.

Conclusions These data, in the aggregate, provide physiological and biochemical evidence to support the concept that the coordinate increases in muscarinic receptor number and Gi levels in heart failure are coupled to increased inhibition of adenylyl cyclase activity and an increased inhibition of myocardial contractility.


Key Words: receptors • proteins • heart failure • nervous system, autonomic • signal transduction




This article has been cited by other articles:


Home page
CirculationHome page
H. Ruan, S. Mitchell, M. Vainoriene, Q. Lou, L.-H. Xie, S. Ren, J. I. Goldhaber, and Y. Wang
Gi{alpha}1-Mediated Cardiac Electrophysiological Remodeling and Arrhythmia in Hypertrophic Cardiomyopathy
Circulation, August 7, 2007; 116(6): 596 - 605.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E.J.F. Danson, Y.H. Zhang, C.E. Sears, A.R. Edwards, B. Casadei, and D.J. Paterson
Disruption of inhibitory G-proteins mediates a reduction in atrial {beta}-adrenergic signaling by enhancing eNOS expression
Cardiovasc Res, September 1, 2005; 67(4): 613 - 623.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Bibevski and M. E. Dunlap
Prevention of diminished parasympathetic control of the heart in experimental heart failure
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Dunlap, S. Bibevski, T. L. Rosenberry, and P. Ernsberger
Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1632 - H1640.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Okumura, J.-i. Kawabe, A. Yatani, G. Takagi, M.-C. Lee, C. Hong, J. Liu, I. Takagi, J. Sadoshima, D. E. Vatner, et al.
Type 5 Adenylyl Cyclase Disruption Alters Not Only Sympathetic But Also Parasympathetic and Calcium-Mediated Cardiac Regulation
Circ. Res., August 22, 2003; 93(4): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jain, C. C. Lim, K. Nagata, V. M. Davis, D. S. Milstone, R. Liao, and R. M. Mortensen
Targeted inactivation of G{alpha}i does not alter cardiac function or {beta}-adrenergic sensitivity
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H569 - H575.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Nagata, C. Ye, M. Jain, D. S. Milstone, R. Liao, and R. M. Mortensen
G{alpha}i2 but Not G{alpha}i3 Is Required for Muscarinic Inhibition of Contractility and Calcium Currents in Adult Cardiomyocytes
Circ. Res., November 10, 2000; 87(10): 903 - 909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-J. Du, X.-M. Gao, G. L. Jennings, A. M. Dart, and E. A. Woodcock
Preserved ventricular contractility in infarcted mouse heart overexpressing beta 2-adrenergic receptors
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2456 - H2463.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-J. Du, D. J. Autelitano, R. J. Dilley, B. Wang, A. M. Dart, and E. A. Woodcock
{beta}2-Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis
Circulation, January 4, 2000; 101(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Huang, S. Wang, D. Qin, M. Boutjdir, and N. El-Sherif
Diminished Basal Phosphorylation Level of Phospholamban in the Postinfarction Remodeled Rat Ventricle : Role of {beta}-Adrenergic Pathway, Gi Protein, Phosphodiesterase, and Phosphatases
Circ. Res., October 29, 1999; 85(9): 848 - 855.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. M Borst, P. Szalai, N. Herzog, W. Kubler, and R. H Strasser
Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes
Cardiovasc Res, October 1, 1999; 44(1): 113 - 120.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Bibevski and M. E. Dunlap
Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure
Circulation, June 8, 1999; 99(22): 2958 - 2963.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota, and P. Merlet
Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy : An In Vivo PET Study
Circulation, November 18, 1997; 96(10): 3416 - 3422.
[Abstract] [Full Text]